The Progression of Cardiometabolic Disease: Validation of a New Cardiometabolic Disease Staging System Applicable to Obesity

To validate a Cardiometabolic Disease Staging (CMDS) system for assigning risk level for diabetes, and all‐cause and cardiovascular disease (CVD) mortality.

• Publication year

  2013

• Venue

  Obesity

• Publication date

  2013-09-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/oby.20585PMID 23894121PMCID 3866217
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

  2015cited by this paper
• Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*

  2013cited by this paper
• Long-Term Outcomes After Bariatric Surgery: Fifteen-Year Follow-Up of Adjustable Gastric Banding and a Systematic Review of the Bariatric Surgical Literature

  2013cited by this paper
• Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033–1046

  2013cited by this paper
• Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management

  2013influential reference
• Faculty Opinions recommendation of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2013cited by this paper
• American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement

  2013cited by this paper
• Economic Costs of Diabetes in the U.S. in 2012

  2013cited by this paper
• AACE comprehensive diabetes management algorithm 2013.

  2013cited by this paper
• Refractory pituitary granulomatosis with polyangiitis (Wegener's) treated with rituximab.

  2013cited by this paper
• Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.

  2012cited by this paper
• Two-year sustained weight loss and metabolic benefits with controlled-release Phentermine/Topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

  2012cited by this paper
• Diabetes Prevention Program

  2012cited by this paper
• Incident Cardiovascular Disease Events in Metabolically Benign Obese Individuals

  2012cited by this paper
• Are there still healthy obese patients?

  2012cited by this paper
• National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

  2011cited by this paper
• Intramyocellular Lipid and Insulin Resistance: Differential Relationships in European and African Americans

  2011cited by this paper
• Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

  2011cited by this paper
• Comparison of Accuracy of Diabetes Risk Score and Components of the Metabolic Syndrome in Assessing Risk of Incident Type 2 Diabetes in Inter99 Cohort

  2011cited by this paper
• Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity

  2011cited by this paper
• Performance of A1C for the Classification and Prediction of Diabetes

  2010cited by this paper
• Multicenter, placebo-controlled trial of lorcaserin for weight management.

  2010cited by this paper
• 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

  2008cited by this paper
• The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

  2008cited by this paper
• Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.

  2006influential reference
• Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus

  2005influential reference
• Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age?

  2005cited by this paper
• Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report From the Women’s Ischemia Syndrome Evaluation (WISE) Study

  2004cited by this paper
• Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia.

  2004influential reference
• Diet, insulin resistance, and obesity: zoning in on data for Atkins dieters living in South Beach.

  2004cited by this paper
• Economic costs of diabetes in the US in 2002.

  2003cited by this paper
• The diabetes risk score: a practical tool to predict type 2 diabetes risk.

  2003cited by this paper
• Waist–hip ratio is the dominant risk factor predicting cardiovascular death in Australia

  2003cited by this paper
• The diabetes prevention program

  2003cited by this paper
• The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

  2001cited by this paper
• MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION

  2000cited by this paper
• Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

  1998cited by this paper
• Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

  1998cited by this paper
• Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

  1998cited by this paper
• Abdominal adiposity and coronary heart disease in women.

  1998cited by this paper
• Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale.

  1997cited by this paper
• Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

  1993cited by this paper
• CARDIA: study design, recruitment, and some characteristics of the examined subjects.

  1988cited by this paper
• Third national health and nutrition examination survey

  1985cited by this paper

• Cardio-metabolic risk among healthcare providers: A latent profile study

  2025cites this paper
• Provider Lifestyle Counseling Among Adults With Cardiometabolic Disease Diagnosis Differs by Sociodemographic Characteristics and Lifestyle Modification: NHANES 2017-2020.

  2025cites this paper
• Integrating genetics, metabolites, and clinical characteristics in predicting cardiometabolic health outcomes using machine learning algorithms - A systematic review

  2025cites this paper
• The association between dietary iron intake and the incidence of cardiometabolic multimorbidity: the mediating role of biological age

  2025cites this paper
• State-of-the-art digital phenotyping methods for cardiometabolic risk prevention and management: a scoping review

  2025cites this paper
• American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease - 2025 Update.

  2025cites this paper
• “Goldilocks day”: identifying the optimal awake movement behaviour composition for predicted cardiometabolic health outcomes in youth

  2025cites this paper
• Inflammation mediates the relationship between cardiometabolic index and vulnerable plaque in patients with acute coronary syndrome

  2025cites this paper
• Selenium and selenium compounds for regulating T2DM and its related gut microbiota dysbiosis: Current findings and challenges

  2025cites this paper
• Policy models for preventative interventions in cardiometabolic diseases: a systematic review

  2025cites this paper
• Vitamin E and Fatty Acid Intake and Cardiometabolic Multimorbidity Risk: The Mediating Role of Plasma Lipid Metabolites

  2025cites this paper
• Association of Triglyceride-Glucose-Related Obesity Indices With All-Cause and Cardiovascular Mortality Among Individuals With Hyperuricemia: A Retrospective Cohort Study.

  2025cites this paper
• Deciphering the tripartite interaction of urbanized environment, gut microbiome and cardio-metabolic disease.

  2025cites this paper
• Gender differences in the relationship between cardiometabolic index and all-cause and specific mortality in the United States adults: a national study

  2025cites this paper
• Adding social determinants of health to the equation: Development of a cardiometabolic disease staging model using clinical and social determinants of health to predict type 2 diabetes

  2025cites this paper
• The race-based stress reduction intervention (RiSE) study on African American women in NYC and Chicago: Design and methods for complex genomic analysis

  2024cites this paper
• ANMCO (Italian Association of Hospital Cardiologists) scientific statement: obesity in adults—an approach for cardiologists

  2024cites this paper
• The relationship between xerostomia and periodontal status in patients with cardiovascular diseases and type 2 diabetes

  2024influential citation
• Primary and residual cardiometabolic risk factors among young adults in a Russian city

  2024influential citation
• Circulating Extracellular Mitochondria in Cardiometabolic Disease: Harnessing the Potential for Diagnosis, Prognosis, and Treatment

  2024cites this paper
• NUTRITIONAL AND HEALTH BENEFITS OF DIETARY RESISTANT STARCH: A REVIEW

  2024cites this paper
• The onset and the development of cardiometabolic aging: an insight into the underlying mechanisms

  2024cites this paper
• The conceptualisation of cardiometabolic disease policy model in the UK

  2024cites this paper
• Serum selenium accelerates the development of metabolic disorders in a metabolically healthy obese U.S. population: a retrospective cross-sectional analysis of a population-based study from the NHANES (2011-2018)

  2024cites this paper
• The impact of cardiovascular health on mortality in US adults with cardiometabolic disease: A prospective nationwide cohort study.

  2024cites this paper
• Propolis supplementation can reduce serum level of interleukin-6, C-reactive protein, and tumor necrosis factor-α: an updated systematic review and dose-response meta-analysis on randomized clinical trials

  2024cites this paper
• Is systemic inflammation a missing link between cardiometabolic index with mortality? Evidence from a large population-based study

  2024cites this paper
• Cardiometabolic Disease Staging and Major Adverse Cardiovascular Event Prediction in 2 Prospective Cohorts

  2024cites this paper
• Transcription factor EB: A potential integrated network regulator in metabolic-associated cardiac injury.

  2023cites this paper
• Concept of healthy body image in Spanish women

  2023cites this paper
• Psychiatric comorbidities in women with cardiometabolic conditions with and without ADHD: a population-based study

  2023cites this paper
• The association of adolescent fitness with cardiometabolic diseases in late adulthood: A 45‐year longitudinal study

  2023cites this paper
• Body mass index trajectories and mortality risk in Japan using a population-based prospective cohort study: the Japan Public Health Center-based Prospective Study

  2023cites this paper
• Bioactive compounds found in Cucumis sativus demonstrate optimal binding affinity to PTP1B.

  2023cites this paper
• Obesity: A Review of Pathophysiology and Classification.

  2023cites this paper
• Metabolomics and mitochondrial dysfunction in cardiometabolic disease.

  2023cites this paper
• Burden of cardiometabolic risk factors and preclinical target organ damage among adults in Freetown, Sierra Leone: a community-based health-screening survey.

  2023influential citation
• Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT‐1 trial

  2023cites this paper
• Association of estimated carotid-femoral pulse wave velocity with frailty in middle-aged and older adults with cardiometabolic disease

  2023cites this paper
• Effect of semaglutide 2.4 mg once weekly on 10‐year type 2 diabetes risk in adults with overweight or obesity

  2023cites this paper
• Machine and deep learning for longitudinal biomedical data: a review of methods and applications

  2023cites this paper
• Protein supplementation changes gut microbial diversity and derived metabolites in subjects with type 2 diabetes

  2023cites this paper
• Cardiac Structure and Function in Young Adults With Various Cardiometabolic Profiles

  2023cites this paper
• Resistant starch improves cardiometabolic disease outcomes: A narrative review of randomized trials.

  2023cites this paper
• Does this person have obesity?

  2023cites this paper
• Burden of cardiometabolic risk factors and preclinical target organ damage among adults in Freetown, Sierra Leone: a community-based health-screening survey

  2023cites this paper
• High risk of renal outcome of metabolic syndrome independent of diabetes in patients with CKD stage 1–4: The ICKD database

  2023cites this paper
• Features of the formation of menopausal metabolic syndrome in arterial hypertension

  2023cites this paper
• Decreased myostatin in response to a controlled DASH diet is associated with improved body composition and cardiometabolic biomarkers in older adults: results from a controlled-feeding diet intervention study

  2022cites this paper
• Impact of objectively-measured sleep duration on cardiometabolic health: A systematic review of recent evidence

  2022cites this paper
• Effect of dietary inflammatory potential on the aging acceleration for cardiometabolic disease: A population-based study

  2022cites this paper
• Potential Benefits of Selenium Supplementation in Reducing Insulin Resistance in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis

  2022cites this paper
• Metabolically healthy obesity: it is time to consider its dynamic changes

  2022cites this paper
• Cardiometabolic diseases, polygenic risk score, APOE genotype, and risk of incident dementia: A population-based prospective cohort study.

  2022cites this paper
• Effects of Health Coaching on Cardiometabolic Health in Middle-Aged Adults: A Systematic Review and Meta-analysis

  2022cites this paper
• Features of hemodynamic and structural parameters of the heart in young people with varying stages of cardiometabolic risk

  2022cites this paper
• Prevalence of adiposity-based chronic disease and its association with anthropometric and clinical indices: a cross-sectional study

  2022cites this paper
• Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases

  2022influential citation
• American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.

  2022cites this paper
• Why Should Pistachio Be a Regular Food in Our Diet?

  2022cites this paper
• The Edmonton Obesity Staging System and pregnancy outcomes in women with overweight or obesity: A secondary analysis of a randomized controlled trial

  2022cites this paper
• The Diagnosis and Management of Cardiometabolic Risk and Cardiometabolic Syndrome after Spinal Cord Injury

  2022cites this paper
• Exploring a Need for a Cardiometabolic Disease Staging System as a Computerized Clinical Decision Support Tool: Qualitative Study

  2022influential citation
• Race Versus Social Determinants of Health in COVID-19 Hospitalization Prediction

  2022cites this paper
• American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).

  2022cites this paper
• Impact of fiber-fortified food consumption on anthropometric measurements and cardiometabolic outcomes: A systematic review, meta-analyses, and meta-regressions of randomized controlled trials

  2022cites this paper
• Higher Inflammation Is Associated with Cardiometabolic Phenotype and Biochemical Health in Women with Obesity

  2022cites this paper
• The effects of propolis supplementation on metabolic parameters: A systematic review and meta-analysis of randomized controlled clinical trials

  2021cites this paper
• The potential of artificial intelligence in enhancing adult weight loss: a scoping review

  2021cites this paper
• How to provide a structured clinical assessment of a patient with overweight or obesity

  2021cites this paper
• Arterial Stiffness and Cardiometabolic-Based Chronic Disease: The Kardiovize Study.

  2021cites this paper
• Cardiometabolic Changes in Response to a Calorie-Restricted DASH Diet in Obese Older Adults

  2021cites this paper
• Visceral fat area and cardiometabolic risk: The Kardiovize study.

  2021cites this paper
• ARTERIAL STIFFNESS.

  2021cites this paper
• Cultural validation and language translation of the scientific SCI exercise guidelines for use in Indonesia, Japan, Korea, and Thailand

  2021cites this paper
• Changes in Cardiometabolic Risk Among Older Adults with Obesity: An Ancillary Analysis of a Randomized Controlled Trial Investigating Exercise Plus Weight Maintenance and Exercise Plus Intentional Weight Loss by Caloric Restriction.

  2021cites this paper
• Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China

  2021cites this paper
• Machine Learning for Assessment of Cardiometabolic Risk Factors Predictive Potential and Prediction of Obstructive Coronary Arteries Lesions

  2021cites this paper
• Obesity treatment: Weight loss versus increasing fitness and physical activity for reducing health risks

  2021cites this paper
• Complications of Obesity

  2021cites this paper
• Addressing the gaps in nutritional care before and during pregnancy

  2021cites this paper
• Developing a Complex Understanding of Physical Activity in Cardiometabolic Disease from Low-to-Middle-Income Countries—A Qualitative Systematic Review with Meta-Synthesis

  2021cites this paper
• Insulin resistance persists despite a metabolically healthy obesity phenotype

  2021cites this paper
• New Horizons. A New Paradigm for Treating to Target with Second-Generation Obesity Medications

  2021cites this paper
• Nephrological Aspects of Metabolic Syndrome in Patients with Chronic Kidney Disease on Peritoneal Dialysis with Different Clinical Variants of Coronary Heart Disease

  2021cites this paper
• Coronavirus Disease 2019 and Cardiometabolic Disease

  2021cites this paper
• Classification of obesity, cardiometabolic risk, and metabolic syndrome in adults with spinal cord injury

  2020cites this paper
• Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study

  2020cites this paper
• Dietary anti-inflammatory index, metabolic syndrome and transition in metabolic status; a gender-specific analysis of ATTICA prospective study.

  2020cites this paper
• Comparing the Ability of Two Comprehensive Clinical Staging Systems to Predict Mortality: EOSS and CMDS

  2020influential citation
• Effects of Melissa officinalis (Lemon Balm) on cardio‐metabolic outcomes: A systematic review and meta‐analysis

  2020cites this paper
• Response to “The Future of Obesity Diagnostic Coding”

  2020cites this paper
• Fermented Dairy Products, Probiotic Supplementation, and Cardiometabolic Diseases: A Systematic Review and Meta-analysis.

  2020cites this paper
• Apolipoprotein A-IV enhances fatty acid uptake by adipose tissues of male mice via sympathetic activation.

  2020influential citation
• Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity

  2020cites this paper
• Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease

  2020cites this paper
• Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review.

  2020cites this paper
• Impact Of Time-Restricted Feeding On Cardiometabolic Health And Performance Among Firefighters

  2020cites this paper
• Reduced Diet-induced Thermogenesis in Apolipoprotein A-IV Deficient Mice

  2019cites this paper
• Network Analysis of the Potential Role of DNA Methylation in the Relationship between Plasma Carotenoids and Lipid Profile

  2019cites this paper